$180.06 Million in Sales Expected for Medidata Solutions Inc (NASDAQ:MDSO) This Quarter

Share on StockTwits

Wall Street analysts forecast that Medidata Solutions Inc (NASDAQ:MDSO) will report sales of $180.06 million for the current fiscal quarter, Zacks reports. Eight analysts have made estimates for Medidata Solutions’ earnings. The lowest sales estimate is $179.00 million and the highest is $181.02 million. Medidata Solutions posted sales of $155.91 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 15.5%. The firm is expected to report its next quarterly earnings results on Tuesday, July 23rd.

On average, analysts expect that Medidata Solutions will report full year sales of $740.14 million for the current year, with estimates ranging from $737.50 million to $742.40 million. For the next fiscal year, analysts forecast that the business will post sales of $852.14 million, with estimates ranging from $840.00 million to $865.65 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Medidata Solutions.

Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Tuesday, April 30th. The company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. Medidata Solutions had a net margin of 7.99% and a return on equity of 9.28%. The business had revenue of $173.50 million during the quarter, compared to the consensus estimate of $172.12 million. During the same quarter last year, the firm earned $0.40 earnings per share. Medidata Solutions’s quarterly revenue was up 16.3% on a year-over-year basis.

MDSO has been the subject of several research analyst reports. JPMorgan Chase & Co. initiated coverage on shares of SEA in a research note on Wednesday, June 12th. They issued an “overweight” rating and a $36.00 price target for the company. Zacks Investment Research downgraded shares of Great Portland Estates from a “hold” rating to a “sell” rating in a research note on Tuesday, April 16th. Dougherty & Co downgraded shares of Medidata Solutions from a “buy” rating to a “neutral” rating in a research note on Wednesday, May 1st. William Blair downgraded shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 12th. Finally, BidaskClub downgraded shares of Zynga from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, March 20th. One analyst has rated the stock with a sell rating, ten have issued a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $84.24.

MDSO traded up $0.05 during midday trading on Friday, hitting $90.95. The company had a trading volume of 39,021 shares, compared to its average volume of 1,025,082. Medidata Solutions has a 52 week low of $60.10 and a 52 week high of $98.60. The company has a quick ratio of 2.57, a current ratio of 2.57 and a debt-to-equity ratio of 0.29. The stock has a market cap of $5.65 billion, a P/E ratio of 94.75, a price-to-earnings-growth ratio of 7.48 and a beta of 1.22. The stock’s 50 day simple moving average is $91.09.

In other news, Director Robert Taylor sold 3,294 shares of the business’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $90.88, for a total transaction of $299,358.72. Following the completion of the sale, the director now directly owns 41,757 shares of the company’s stock, valued at $3,794,876.16. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 4.70% of the company’s stock.

Large investors have recently bought and sold shares of the company. Quadrant Capital Group LLC increased its position in shares of Medidata Solutions by 126.8% during the first quarter. Quadrant Capital Group LLC now owns 592 shares of the company’s stock worth $40,000 after acquiring an additional 331 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its position in shares of Medidata Solutions by 26.9% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 1,286 shares of the company’s stock worth $87,000 after acquiring an additional 273 shares in the last quarter. Canton Hathaway LLC bought a new stake in shares of Medidata Solutions during the first quarter worth about $109,000. Advisor Group Inc. increased its position in shares of Medidata Solutions by 27.1% during the fourth quarter. Advisor Group Inc. now owns 2,553 shares of the company’s stock worth $173,000 after acquiring an additional 545 shares in the last quarter. Finally, Stephens Inc. AR increased its position in shares of Medidata Solutions by 8.7% during the fourth quarter. Stephens Inc. AR now owns 2,722 shares of the company’s stock worth $184,000 after acquiring an additional 218 shares in the last quarter.

Medidata Solutions Company Profile

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.

Featured Article: Forex

Get a free copy of the Zacks research report on Medidata Solutions (MDSO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks: BankFinancial Co.  Receives Average Recommendation of “Hold” from Analysts
Zacks: BankFinancial Co. Receives Average Recommendation of “Hold” from Analysts
Burlington Stores Inc  Expected to Announce Quarterly Sales of $1.63 Billion
Burlington Stores Inc Expected to Announce Quarterly Sales of $1.63 Billion
FBL Financial Group  Expected to Announce Earnings of $1.25 Per Share
FBL Financial Group Expected to Announce Earnings of $1.25 Per Share
Analysts Expect Medidata Solutions Inc  to Announce $0.39 EPS
Analysts Expect Medidata Solutions Inc to Announce $0.39 EPS
$507.43 Million in Sales Expected for Columbia Sportswear  This Quarter
$507.43 Million in Sales Expected for Columbia Sportswear This Quarter
$1.60 Earnings Per Share Expected for Magna International Inc.  This Quarter
$1.60 Earnings Per Share Expected for Magna International Inc. This Quarter


© 2006-2019 Ticker Report